Intrinsiqq
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. Insider Trading

SLGL

⊜ Compare
Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
None
in the last two years

Get an email when SLGL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 10 – 11
    Opaleye Management Inc.
    Large holder · bought 3,124 at avg $66.39
    207K
    0.6% of stake
  • Sep 4 – 9
    Opaleye Management Inc.
    Large holder · bought 9,976 at avg $68.88
    687K
    1.8% of stake
  • Sep 1 – 2
    Opaleye Management Inc.
    Large holder · bought 1,683 at avg $69.22
    116K
    0.3% of stake
  • Aug 28 – 31
    Opaleye Management Inc.
    Large holder · bought 40,330 at avg $69.19
    $2.79M
    8.1% of stake
  • Aug 12
    Opaleye Management Inc.
    Large holder · bought 951 at $71.50
    68K
    0.2% of stake
  • Jul 13 – 14
    Opaleye Management Inc.
    Large holder · bought 1,695 at avg $73.64
    125K
    0.3% of stake
  • Jul 8 – 10
    Opaleye Management Inc.
    Large holder · bought 529 at avg $73.80
    39K
    0.1% of stake
  • Jul 1 – 2
    Opaleye Management Inc.
    Large holder · bought 1,712 at avg $71.97
    123K
    0.3% of stake
  • May 20
    Opaleye Management Inc.
    Large holder · bought 1,563 at $64.43
    101K
    0.3% of stake
  • May 12 – 13
    Opaleye Management Inc.
    Large holder · bought 3,437 at avg $67.35
    231K
    0.7% of stake
  • Mar 24
    Opaleye Management Inc.
    Large holder · bought 39,665 at avg $72.00
    $2.86M
    8.6% of stake
  • Feb 13
    Opaleye Management Inc.
    Large holder · bought 291 at $63.00
    18K
    <0.1% of stake
  • Feb 2
    Opaleye Management Inc.
    Large holder · bought 100 at $58.00
    6K
    <0.1% of stake
  • Jan 27
    Opaleye Management Inc.
    Large holder · bought 100 at $57.05
    6K
    <0.1% of stake
  • Jan 22 – 23
    Opaleye Management Inc.
    Large holder · bought 3,324 at avg $56.37
    187K
    0.7% of stake
  • Jan 2 – 5
    Opaleye Management Inc.
    Large holder · bought 2,592 at avg $42.00
    109K
    0.6% of stake
  • Dec 29, 2025 – Dec 31, 2025
    Opaleye Management Inc.
    Large holder · bought 66,304 at avg $41.97
    $2.78M
    17% of stake
  • Dec 22, 2025 – Dec 26, 2025
    Opaleye Management Inc.
    Large holder · bought 2,905 at avg $41.49
    121K
    0.8% of stake
  • Dec 17, 2025
    Opaleye Management Inc.
    Large holder · bought 2,735 at $40.37
    110K
    0.7% of stake
  • Dec 12, 2025
    Opaleye Management Inc.
    Large holder · bought 87 at $40.00
    3K
    <0.1% of stake
  • Dec 5, 2025 – Dec 8, 2025
    Opaleye Management Inc.
    Large holder · bought 744 at avg $39.61
    29K
    0.2% of stake
  • Dec 1, 2025 – Dec 3, 2025
    Opaleye Management Inc.
    Large holder · bought 6,864 at avg $37.53
    258K
    1.8% of stake
  • Nov 24, 2025 – Nov 26, 2025
    Opaleye Management Inc.
    Large holder · bought 949 at avg $39.97
    38K
    0.3% of stake
  • Nov 20, 2025
    Opaleye Management Inc.
    Large holder · bought 5,784 at $35.83
    207K
    1.6% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SLGL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SLGL

CompareIntrinsic value
EVFMEvofem Biosciences Inc.
$0.01+0.00%15
SCYXScynexis, Inc.
$3.84-2.54%40
QUREuniQure N.V.
$23.07-3.35%10
CRNXCrinetics Pharmaceuticals Inc.
No recent price40
TNXPTonix Pharmaceuticals Holding Corp
$5.11-1.54%40
NAMSNewAmsterdam Pharma Co. N.V.
$20.93+5.18%10
NEUPNeuphoria Therapeutics Inc.
$2.98-0.33%10
PYXSPyxis Oncology, Inc.
$1.66+1.22%10

Held by ETFs

SLGL is in 1 US ETF. The largest of them, with SLGL's weight in each:

Spot a number that looks wrong? Check it in SLGL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SLGL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.